Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Niidae Wiki
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Corporate haven
(section)
Page
Discussion
English
Read
Edit
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==IP–based Tax inversions== {{main|Corporate tax inversion|Leprechaun economics}} [[File:Ireland Trade Good Discrepancy (1995-2017).png|thumb|Apple's Q1 2015 Irish "quasi-inversion" of its $300bn international IP (known as [[leprechaun economics]]), is the largest recorded individual BEPS action in history, and almost double the 2016 $160bn Pfizer-Allergan Irish inversion, which was blocked.<br/><br/>[[Brad Setser]] & Cole Frank<br/>(Council on Foreign Relations)<ref name="cofr"/>]] ===Apple vs. Pfizer–Allergan=== Modern corporate tax havens further leverage their IP-based BEPS toolbox to enable international corporates to execute quasi-tax inversions, which could otherwise be blocked by domestic anti-inversion rules. The largest example was Apple's Q1 January 2015 restructuring of its Irish business, Apple Sales International, in a quasi-tax inversion, which led to the [[Paul Krugman]] labeled "[[leprechaun economics]]" affair in Ireland in July 2016 (see article). In early 2016, the Obama Administration blocked the proposed $160 billion Pfizer-Allergan Irish corporate tax inversion,<ref>{{cite news|url=https://www.independent.ie/business/irish/pfizer-pulls-out-of-140bn-irish-allergan-merger-34603518.html|title=Pfizer pulls out of €140bn Irish Allergan merger|newspaper=Irish Independent|date=6 April 2016|access-date=16 May 2018|archive-url=https://web.archive.org/web/20180708104847/https://www.independent.ie/business/irish/pfizer-pulls-out-of-140bn-irish-allergan-merger-34603518.html|archive-date=8 July 2018|url-status=live|df=dmy-all}}</ref><ref>{{cite news|url=https://www.bloomberg.com/gadfly/articles/2016-04-06/big-pharma-ruined-tax-inversions-for-everybody|title=Big Pharma Murdered Tax Inversions|newspaper=Bloomberg.com|publisher=Bloomberg News|date=6 August 2016|access-date=16 May 2018|archive-url=https://web.archive.org/web/20180417030218/https://www.bloomberg.com/gadfly/articles/2016-04-06/big-pharma-ruined-tax-inversions-for-everybody|archive-date=17 April 2018|url-status=live|df=dmy-all}}</ref> the largest proposed corporate [[tax inversion]] in history,<ref>{{cite news|title = US issues new rules to clamp down on tax 'inversions'|url = https://www.irishtimes.com/business/economy/us-issues-new-rules-to-clamp-down-on-tax-inversions-1.2829090|newspaper = The Irish Times|date = 16 October 2016|access-date = 16 May 2018|archive-url = https://web.archive.org/web/20180417022904/https://www.irishtimes.com/business/economy/us-issues-new-rules-to-clamp-down-on-tax-inversions-1.2829090|archive-date = 17 April 2018|url-status = live|df = dmy-all}}</ref> a decision which the Trump Administration also upheld.<ref>{{cite news|url=https://www.reuters.com/article/us-usa-tax-inversions/trump-to-keep-obama-rule-curbing-corporate-tax-inversion-deals-idUSKBN1C92RQ|title=Trump to keep Obama rule curbing corporate tax inversion deals|work=Reuters|date=4 October 2017|access-date=16 May 2018|archive-url=https://web.archive.org/web/20180616054152/https://www.reuters.com/article/us-usa-tax-inversions/trump-to-keep-obama-rule-curbing-corporate-tax-inversion-deals-idUSKBN1C92RQ|archive-date=16 June 2018|url-status=live|df=dmy-all}}</ref><ref>{{cite web|url=http://www.ey.com/Publication/vwLUAssets/Report_on_recent_US_international_tax_developments_-_20_January_2017/$FILE/2017G_00259-171Gbl_Report%20on%20recent%20US%20international%20tax%20developments%20-%2020%20January%202017.pdf|title=Global Tax Aleart Corporate Inversions|publisher=Ernst & Young|date=20 January 2017|access-date=16 May 2018|archive-url=https://web.archive.org/web/20180418225844/http://www.ey.com/Publication/vwLUAssets/Report_on_recent_US_international_tax_developments_-_20_January_2017/$FILE/2017G_00259-171Gbl_Report%20on%20recent%20US%20international%20tax%20developments%20-%2020%20January%202017.pdf|archive-date=18 April 2018|url-status=dead|df=dmy-all}}</ref> However, both Administrations were silent when the Irish State announced in July 2016 that 2015 GDP has risen 26.3% in one quarter due to the "onshoring" of corporate IP, and it was rumoured to be Apple.<ref>{{cite news|url=https://www.irishexaminer.com/ireland/apple-tax-affairs-changes-triggered-surge-in-irish-economy-419912.html|title=Apple tax affairs changes triggered a surge in Irish economy|newspaper=The Irish Examiner|date=18 September 2016|access-date=16 May 2018|archive-url=https://web.archive.org/web/20180330012241/https://www.irishexaminer.com/ireland/apple-tax-affairs-changes-triggered-surge-in-irish-economy-419912.html|archive-date=30 March 2018|url-status=live|df=dmy-all}}</ref> It might have been due to the fact that the [[Central Statistics Office (Ireland)]] openly delayed and limited its normal data release to protect the confidentiality of the source of the growth.<ref name="cso"/> It was only in early 2018, almost three years after Apple's Q1 2015 $300 billion quasi-tax inversion to Ireland (the largest tax inversion in history), that enough Central Statistics Office (Ireland) data was released to prove it definitively was Apple.<ref name="brads">{{Cite web|title=Apple's Exports Aren't Missing: They Are in Ireland|url=https://www.cfr.org/blog/apples-exports-arent-missing-they-are-ireland|publisher=Council on Foreign Relations|date=30 October 2017|access-date=16 May 2018|archive-url=https://web.archive.org/web/20180429025322/https://www.cfr.org/blog/apples-exports-arent-missing-they-are-ireland|archive-date=29 April 2018|url-status=dead|df=dmy-all}}</ref><ref name="cofr"/><ref name="cffy">{{cite web|url=http://economic-incentives.blogspot.ie/2018/01/what-apple-did-next.html|title=What Apple did next|publisher=Seamus Coffey, University College Cork|date=24 January 2018|access-date=16 May 2018|archive-url=https://web.archive.org/web/20180330153810/http://economic-incentives.blogspot.ie/2018/01/what-apple-did-next.html|archive-date=30 March 2018|url-status=dead|df=dmy-all}}</ref> Financial commentators estimate Apple onshored circa $300 billion in IP to Ireland, effectively representing the balance sheet of Apple's non-U.S. business.<ref name="cofr"/> Thus, Apple completed a quasi-inversion of its non-U.S. business, to itself, in Ireland, which was almost twice the scale of Pfizer-Allergan's $160 billion blocked inversion. ===Apple's IP–based BEPS inversion=== Apple used Ireland's new BEPS tool, and "[[double Irish]]" replacement, the "[[double Irish arrangement#Backstop of capital allowances|capital allowances for intangible assets]]" scheme.<ref name="cffy"/> This BEPS tool enables corporates to write-off the "arm's length" (to be OECD-compliant), intergroup acquisition of offshored IP, against all Irish corporate taxes. The "arm's length" criteria are achieved by getting a major accounting firm in Ireland's [[International Financial Services Centre, Dublin|International Financial Services Centre]] to conduct a valuation, and Irish GAAP audit, of the IP. The range of IP acceptable by the Irish [[Revenue Commissioners]] is very broad. This BEPS tool can be continually replenished by acquiring new offshore IP with each new "product cycle".<ref name="maples">{{cite web|url=https://www.scribd.com/document/377485537/Maples-and-Calder-Ireland-Intellectual-Property-2018|title=Maples and Calder Irish Intellectual Property Tax Regime - 2.5% Effective Tax|publisher=[[Maples and Calder]] Law Firm|date=February 2018|access-date=2018-05-13|archive-url=https://web.archive.org/web/20180516033549/https://www.scribd.com/document/377485537/Maples-and-Calder-Ireland-Intellectual-Property-2018|archive-date=2018-05-16|url-status=live}}</ref> In addition, Ireland's 2015 Finance Act removed the 80% cap on this tool (which forced a minimum 2.5% [[Corporation tax in the Republic of Ireland#Effective tax rate (ETR)|effective tax rate]]), thus giving Apple a 0% effective tax rate on the "onshored" IP. Ireland then restored the 80% cap in 2016 (and a return to a minimum 2.5% effective tax rate), but only for new schemes.<ref name="app2">{{cite web|url=https://www.independent.ie/business/budget/tax-break-for-ip-transfers-is-cut-to-80pc-36215540.html|title=Tax break for IP transfers is cut to 80pc|work=Irish Independent|date=11 October 2017|access-date=16 May 2018|archive-url=https://web.archive.org/web/20180322015127/https://www.independent.ie/business/budget/tax-break-for-ip-transfers-is-cut-to-80pc-36215540.html|archive-date=22 March 2018|url-status=live|df=dmy-all}}</ref><ref name="app1">{{cite news|url=https://www.irishtimes.com/business/economy/cliff-taylor-noonan-and-donohoe-rule-switching-could-cost-1bn-next-year-1.3283383?mode=sample&auth-failed=1&pw-origin=https%3A%2F%2Fwww.irishtimes.com%2Fbusiness%2Feconomy%2Fcliff-taylor-noonan-and-donohoe-rule-switching-could-cost-1bn-next-year-1.3283383|title=Change in tax treatment of intellectual property and subsequent and reversal hard to fathom|newspaper=The Irish Times|date=8 November 2017|access-date=16 May 2018|archive-url=https://web.archive.org/web/20180321151140/https://www.irishtimes.com/business/economy/cliff-taylor-noonan-and-donohoe-rule-switching-could-cost-1bn-next-year-1.3283383?mode=sample&auth-failed=1&pw-origin=https%3A%2F%2Fwww.irishtimes.com%2Fbusiness%2Feconomy%2Fcliff-taylor-noonan-and-donohoe-rule-switching-could-cost-1bn-next-year-1.3283383|archive-date=21 March 2018|url-status=live|df=dmy-all}}</ref> Thus, Apple was able to achieve what Pfizer-Allergan could not, by making use of Ireland's advanced IP-based BEPS tools. Apple avoided any U.S regulatory scrutiny/blocking of its actions, as well as any wider U.S. public outcry, as Pfizer-Allergan incurred. Apple structured an Irish corporate effective tax rate of close to zero on its non-U.S. business, at twice the scale of the Pfizer-Allergan inversion. {{quote|I cannot see a justification for giving full Irish tax relief to the intragroup acquisition of a virtual asset, except that it is for the purposes of facilitating corporate tax avoidance.|source=Professor Jim Stewart, Trinity College Dublin, "MNE Tax Strategies in Ireland", 2016<ref>{{Cite web|title=MNE Tax Strategies in Ireland|url=https://www.tcd.ie/business/assets/pdf/MNE-tax-strategies-and-ireland.pdf|publisher=Trinity College Dublin|date=2016|access-date=2018-05-16|archive-url=https://web.archive.org/web/20180426215449/https://www.tcd.ie/business/assets/pdf/MNE-tax-strategies-and-ireland.pdf|archive-date=2018-04-26|url-status=live}}</ref>}}
Summary:
Please note that all contributions to Niidae Wiki may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Encyclopedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Corporate haven
(section)
Add topic